349 related articles for article (PubMed ID: 8613443)
1. Experimental models for the study of drug resistance in osteosarcoma: P-glycoprotein-positive, murine osteosarcoma cell lines.
Takeshita H; Gebhardt MC; Springfield DS; Kusuzaki K; Mankin HJ
J Bone Joint Surg Am; 1996 Mar; 78(3):366-75. PubMed ID: 8613443
[TBL] [Abstract][Full Text] [Related]
2. Intrinsic resistance to chemotherapeutic agents in murine osteosarcoma cells.
Takeshita H; Kusuzaki K; Ashihara T; Gebhardt MC; Mankin HJ; Hirasawa Y
J Bone Joint Surg Am; 2000 Jul; 82-A(7):963-9. PubMed ID: 10901311
[TBL] [Abstract][Full Text] [Related]
3. Characterization of newly established adriamycin resistant human leukemic cell lines (KY-ADR1 and KY-ADR2).
Fukuda T; Kakihara T; Kamishima T; Ohnishi Y; Naito M; Kishi K; Shibata A; Tsuruo T
Leuk Res; 1994 Sep; 18(9):709-15. PubMed ID: 7934146
[TBL] [Abstract][Full Text] [Related]
4. Lack of elevated drug efflux in adriamycin-resistant immunoblastic B lymphoma cells with mdr1 overexpression.
Chao CC
FEBS Lett; 1995 Oct; 373(3):285-90. PubMed ID: 7589484
[TBL] [Abstract][Full Text] [Related]
5. Drug resistance modification using pulsing electromagnetic field stimulation for multidrug resistant mouse osteosarcoma cell line.
Hirata M; Kusuzaki K; Takeshita H; Hashiguchi S; Hirasawa Y; Ashihara T
Anticancer Res; 2001; 21(1A):317-20. PubMed ID: 11299755
[TBL] [Abstract][Full Text] [Related]
6. The multidrug-resistant human lung tumour cell line, DLKP-A10, expresses novel drug accumulation and sequestration systems.
Cleary I; Doherty G; Moran E; Clynes M
Biochem Pharmacol; 1997 May; 53(10):1493-502. PubMed ID: 9260877
[TBL] [Abstract][Full Text] [Related]
7. The expression of mdr-1-related gp-170 and its correlation with anthracycline resistance in renal cell carcinoma cell lines and multidrug-resistant sublines.
Yu DS; Chang SY; Ma CP
Br J Urol; 1998 Oct; 82(4):544-7. PubMed ID: 9806185
[TBL] [Abstract][Full Text] [Related]
8. Reversal of P-glycoprotein-mediated multidrug resistance by XR9051, a novel diketopiperazine derivative.
Dale IL; Tuffley W; Callaghan R; Holmes JA; Martin K; Luscombe M; Mistry P; Ryder H; Stewart AJ; Charlton P; Twentyman PR; Bevan P
Br J Cancer; 1998 Oct; 78(7):885-92. PubMed ID: 9764579
[TBL] [Abstract][Full Text] [Related]
9.
Jiang B; Yan LJ; Wu Q
DNA Cell Biol; 2019 May; 38(5):485-490. PubMed ID: 30977678
[TBL] [Abstract][Full Text] [Related]
10. Anticancer drug sensitivity and expression of multidrug resistance markers in early passage human sarcomas.
Hoffmann J; Schmidt-Peter P; Hänsch W; Naundorf H; Bunge A; Becker M; Fichtner I
Clin Cancer Res; 1999 Aug; 5(8):2198-204. PubMed ID: 10473106
[TBL] [Abstract][Full Text] [Related]
11. Reversion effects of curcumin on multidrug resistance of MNNG/HOS human osteosarcoma cells in vitro and in vivo through regulation of P-glycoprotein.
Si M; Zhao J; Li X; Tian JG; Li YG; Li JM
Chin Med J (Engl); 2013 Nov; 126(21):4116-23. PubMed ID: 24229684
[TBL] [Abstract][Full Text] [Related]
12. P-glycoprotein mediated resistance to 5'-nor-anhydro-vinblastine (Navelbine).
Adams DJ; Knick VC
Invest New Drugs; 1995; 13(1):13-21. PubMed ID: 7499103
[TBL] [Abstract][Full Text] [Related]
13. Avoidance of doxorubicin resistance in osteosarcoma cells using a new quinoline derivative, MS-209.
Takeshita H; Kusuzaki K; Tsuji Y; Hirata M; Hashiguchi S; Nakamura S; Murata H; Ashihara T; Hirasawa Y
Anticancer Res; 1998; 18(2A):739-42. PubMed ID: 9615713
[TBL] [Abstract][Full Text] [Related]
14. Chemosensitisation by verapamil and cyclosporin A in mouse tumour cells expressing different levels of P-glycoprotein and CP22 (sorcin).
Twentyman PR; Reeve JG; Koch G; Wright KA
Br J Cancer; 1990 Jul; 62(1):89-95. PubMed ID: 1975203
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells.
Cole SP; Sparks KE; Fraser K; Loe DW; Grant CE; Wilson GM; Deeley RG
Cancer Res; 1994 Nov; 54(22):5902-10. PubMed ID: 7954421
[TBL] [Abstract][Full Text] [Related]
16. [Expression of MDR1 and GST-pi in osteosarcoma and soft tissue sarcoma and their correlation with chemotherapy resistance].
Wei L; Song XR; Wang XW; Li M; Z uo WS
Zhonghua Zhong Liu Za Zhi; 2006 Jun; 28(6):445-8. PubMed ID: 17152492
[TBL] [Abstract][Full Text] [Related]
17. A study of the mechanism of resistance to Adriamycin in vivo. Glutathione metabolism, P-glycoprotein expression, and drug transport.
Lee FY; Sciandra J; Siemann DW
Biochem Pharmacol; 1989 Nov; 38(21):3697-705. PubMed ID: 2574574
[TBL] [Abstract][Full Text] [Related]
18. ABCG1 and Pgp identify drug resistant, self-renewing osteosarcoma cells.
Roundhill EA; Jabri S; Burchill SA
Cancer Lett; 2019 Jul; 453():142-157. PubMed ID: 30910588
[TBL] [Abstract][Full Text] [Related]
19. Selective drug resistant human osteosarcoma cell lines.
Burns BS; Edin ML; Lester GE; Tuttle HG; Wall ME; Wani MC; Bos GD
Clin Orthop Relat Res; 2001 Feb; (383):259-67. PubMed ID: 11210963
[TBL] [Abstract][Full Text] [Related]
20. Photodynamic inactivation with acridine orange on a multidrug-resistant mouse osteosarcoma cell line.
Kusuzaki K; Minami G; Takeshita H; Murata H; Hashiguchi S; Nozaki T; Ashihara T; Hirasawa Y
Jpn J Cancer Res; 2000 Apr; 91(4):439-45. PubMed ID: 10804293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]